|
Recent Newsletters
Week in Review: ELVIS in the OR | Cardiology leaders oppose Trump policy | COVID-19 updates | Genetic testing |
Acute Coronary Syndrome: Alirocumab & ACS | Breast cancer 60% more fatal for heart attack survivors |
Good financial news for cardiologists | COVID-19’s impact on heart transplants | Genetic testing for heart disease |
Holographic display improves cardiologist accuracy | Alirocumab & ACS outcomes | New self-powered heart monitors |
Vascular & Endovascular: THALES trial results | A 'missed opportunity' for statin use | COVID-19 updates |
Signs of COVID still in blood after 40 days | The world’s smallest endoscope | ACC leaders oppose Trump's WHO decision |
Structural & Congenital Heart Disease: When TAVR fails | CMS proposes coverage updates, name change for TMVR |